Friday, June 2, 2023 | Back issues
Courthouse News Service Courthouse News Service


SACRAMENTO - More than 17 people claim Eli Lilly failed to warn of the frequency and severity of withdrawal symptoms from Cymbalta, a selective serotonin reuptake inhibitor it introduced when it lost its patent on Prozac, in Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.